An interventional study of ePNa in Pneumonia, sponsored by Nathan Dean. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-28.
Sponsored by Nathan Dean · Not applicable, Interventional, and Treatment
Intermountain Health has developed a electronic decision support tool to help doctors provide the best care for pneumonia. The purpose of this study is to enhance the existing tool (called ePneumonia (electronic Pneumonia) or ePNa) so that it can be used at other institutions, and to test deployment of the tool at another institution's hospitals.
This study as funded by the AHRQ (Agency for Healthcare Research and Quality) involves making the current ePNa system a "SMART on FHIR" compatible application that will enable the same core software and processes to work across the Cerner and Epic electronic health record platforms. The investigators will then engage with emergency department providers and patients to improve user centered design, considering clinician preferences and feedback for use as well as patient needs for information. Finally, the investigators will evaluate the feasibility and acceptability via a pilot implementation trial of the interoperable ePNa platform at two Vanderbilt affiliated hospitals.
2,045 studies on the registry are indexed under Pneumonia; 284 are open to participants now.
This study's planned enrollment of 6,917 is above the median of 106 across 1,247 interventional studies indexed under Pneumonia.
Browse Pneumonia studies →This is the only study on the registry with Nathan Dean as lead sponsor.
Counted across the registry records on this site, refreshed daily.
For the baseline database and assessment of clinical outcomes, all data will be pulled from the Epic Clarity data warehouse.
Exclusion Criteria:
For all above patients:
For the groups selected by ICD-10 pneumonia codes, an additional exclusion is:
ePNa (the decision support tool) will be implemented at 2 EDs that are part of the Vanderbilt Health system.
Other: ePNa
Real-time, automated clinical decision support tool for pneumonia (called "ePNa")
14-day hospital-free days
14-day hospital-free days (a metric which captures outpatient disposition from the emergency department, secondary hospital admission, and length of stay)
Time frame: 14 days after initial presentation to the emergency department
30-day all-cause mortality
Time frame: At 30 days after initial ED presentation
ED length of stay (hours)
Time frame: At ED discharge
ICU length of stay (days)
Time frame: At ICU discharge
Number of patients admitted to floor who are subsequently transferred to ICU within 72 hours
Time frame: At 72 hours after inpatient admission
Time from ED presentation to first antibiotic dose (minutes)
Time frame: At time of first antibiotic dose
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.